Search:

A summary of presentations from the weekly Summit partner webinars

January 8, 2026 – The latest Summit Summary

Seasonal Vaccine Coverage Update – Shannon Stokley, DrPH, MPH, Deputy Director of Implementation, NCIRD’s Immunization Services Division (ISD), CDC

Shannon Stokley, DrPH, MPH, gave an update about influenza, COVID-19, and RSV vaccination coverage.

VIEW SLIDES

Influenza, COVID-19, and RSV Vaccination Coverage Update – Shannon Stokley, DrPH, MPH
The main source of data for this report is the National Immunization Survey–Fall Respiratory Virus Module (NIS-FRVM) — formerly “The Adult COVID Module.” Another source of data is the claims database, IQVIA.

Influenza Vaccination Coverage
For adults, based on data from the Behavioral Risk Factor Surveillance System from the 2010-2011 season to today, the United States saw a dip in vaccination coverage for influenza in the 2017-2018 season and, following an increase around the pandemic, has again seen a decline.

  • For 2025 (through December 27) compared with 2024:
    • Among adults, for the flu vaccine: 43.5% have reported receipt; 7% have reported intent to get.
      • These percentages are just slightly higher compared with the same time last season.
      • Coverage is higher among the older population, higher for white and Asian adults compared with Black and Hispanic adults, and higher in urban areas than in rural areas.
      • Vaccination coverage for flu is higher for those with insurance compared to those without.
      • The slightly lower numbers within IQVIA data may be due to lags in the reporting of claims data.
      • The data reported here do not reflect vaccinations administered outside medical offices or pharmacies (e.g., workplace vaccinations).

For children, historically (from 2010 to 2025), according to NIS, there have been declines in vaccine coverage for flu.

  • For 2025 (through December 27) compared with 2024:
    • Among children, for the flu vaccine: 42.5% have reported receipt; 6% have reported intent to get.
      • These percentages are just slightly lower compared with the same time last season.
      • Coverage is higher among younger children; about the same across race/ethnicity, with higher numbers among Hispanic children; rates are higher in urban areas than in rural areas; and there are notable differences aligned with poverty indicators.

COVID-19 Vaccination Coverage
For adults, uptake is lower this season (16.6%) compared with last season (20.4%).

  • Among adults ≥65 years, for the COVID-19 vaccine, vaccination coverage is higher than other age groups, but rates (35.2%) are lower this season than rates (39.6%) last season for this age group.
  • Among adults with a high-risk condition for COVID-19:
    • For ages 18 to 64, the vaccination rate is ~20%
    • For ages ≥65, the vaccination rate is 35.2%
  • Demographic patterns for COVID-19 vaccination coverage are similar to patterns seen for influenza vaccination coverage.

For children, the COVID-19 vaccination rate (7.4%) is much lower among children than among adults and is lower this season than at the same time last season (10.8%). Even factoring in intent to vaccinate, the rate this season is lower than last season.

RSV Vaccination Coverage
For adults, RSV is one lifetime dose, so it is not generally monitored by season.

  • Among adults ≥75 years, the vaccination rate is 41.7%
  • Among adults who are high risk and 50 to 74 years of age, the vaccination rate is 33.1%
  • For adults ≥75, the differences in rates by race and ethnicity and by urban/rural geography are small, but there is a big difference in coverage rates between those who have health insurance and those who do not.
  • For adults who are high risk, there are similar patterns, although Black adults with a high-risk condition are showing higher uptake compared with white or Hispanic adults with a high-risk condition.

For infants, RSV protection comes from either maternal vaccination or monoclonal antibody soon after birth.

Among infants, for the month of November 2025, 43.2% of infants have some protection reported, which is a little bit higher than the number reported for October 2025.

Three websites include information presented here: FluVaxView, COVIDVaxView, and RSVVaxView.

QUESTIONS & ANSWERS

Q: Can you speak at all to trend data for vaccination for the past 10 years, or a larger time frame, versus this year from the last? Has it been trending down?
Shannon Stokley (CDC): We have the most data for flu, and yes, it has been trending down since the pandemic. We had a surge in 2020-2021: There was a lot going on then, with the pandemic and people wanting to be protected. But since then, coverage has been decreasing a little, bit by bit, each year, and that’s for adults and children. We’ve been seeing that decrease. I think COVID’s a little bit different. We’ve had some changes in recommendations. It’s only been around since 2021, but it’s lower than it was when we had the initial introduction of the vaccine. RSV has only been around for a few years.

Q: The data for pregnant women for influenza: Do you have any projections about when that data might be available?
Shannon Stokley (CDC): We anticipate having that data in February. There have been some delays with getting that data, which has been monitored in the past through the Vaccine Safety Data Link. We will be posting that data on the FluVaxView and the COVIDVaxView sites.

Q: About the RSV vaccine: Do you have any data or places we can go to understand what proportion of birthing hospitals are offering the monoclonal antibodies to newborns, or what proportion is being administered in the hospital versus after newborns are discharged?
Shannon Stokley (CDC): I haven’t seen the data yet on what proportion is administered directly in the hospital versus after. However, we did have an MMWR article that came out right at the end of the year, I think right after the shutdown ended, that documented the number of birthing hospitals that have been enrolled in the VFC program, because we were working to increase access, because many of the birthing hospitals weren’t in the VFC program. It showed a 33% increase in enrollment, and we have it by state. And it shows that the hospitals that have been enrolled into the VFC program represent about 40% of the births in the nation. So, we continue to work with the jurisdictions to increase enrollment in the program so that we can increase access to the monoclonal antibody. And then there was another report, using some of our IIS data from the immunization registries for jurisdictions where we had the data, that reported on administrations for the first season. And we did have some of that data by age of the child: whether or not it was administered during the first week, right after birth or the first couple of days, and then later on — because, at least that first season, not everyone could have received it right after birth. But it has some of that information in there. Those are two good reports, and I can follow up with you to share the links and then, hopefully, you can share that with everyone as well.

Q: Do you anticipate any challenges with continuing with the surveillance data and the coverage data as we go forward into this season and into the rest of this year?
Shannon Stokley (CDC): With our plans right now, there are no changes to how we’re collecting data. We are continuing to administer the National Immunization Survey. It’s a new year: They’re starting the data collection for 2026, so that is continuing. We’ll have data for pregnant women soon, that will be coming starting February. So right now, monitoring, based on how we’ve done it in the past, that is still continuing, and I don’t anticipate changes. We should be getting the 2025 data probably in May, so I’m looking forward to seeing that and sharing it.

BACK TO TOP

National Influenza Vaccination Week Wrap-up – Michele Slafkosky, Executive Director, Families Fighting Flue

Michele Slafkosky gave an update about the activities and impacts of National Influenza Vaccination Week.

VIEW SLIDES

National Influenza Vaccination Week Wrap-up – Michele Slafkosky
Families Fighting Flu (FFF) expanded National Influenza Vaccination Week to a 2-week event — National Influenza Vaccination Weeks (NIVWs) from December 1 to December 15.

FFF activities for NIVWs included:

  • Partnering with organizations, such as NFID, to expand reach through webinars and events
  • Providing a resources toolkit for others to share through social media and by partners
  • Launching new or expanded initiatives:
    • Kaden Blaze Campaign, which was built around the comic book by Kaden Blaze, included Kaden’s first book signing, a flu clinic, and the release of the comic book in Spanish, all of which garnered significant media engagement.
    • Social media and TikTok Takeovers and Challenges focused on people across the lifespan and intentionally focusing on reaching new audiences and those with health disparities
    • New YouTube Series targeted to healthcare providers and patients and featuring Dr. Jeb Teichman
    • Faith Leaders Webinar, hosted in partnership with Blue Cross Blue Shield, had 3,540 people in attendance

NIVWs: Results
By expanding partnerships and advocates who support the mission, the two weeks resulted in:

  • Traction on national and local news outlets
  • Expansion of reach — 350M since September 2025
  • Expansion of outreach to new audiences
  • Expansion of reach on TikTok and other social media
  • 500+ comic books distributed during NIVWs

QUESTIONS & ANSWERS

Q: Have you checked to see how closely your coverage updates align with what you’re seeing out of the NIS or CDC?
Michele Slafkosky (FFF): As Shannon was showing those slides and that data, that was fresh on my mind. We’re looking at what they’re reporting, and it’s aligning somewhat. And I think Ruth asked about the 10 years, going back. We’ve recently done that in light of this week, too, because Families Fighting Flu was founded by individuals who all lost a child, and for most on this call, they know how hard they have worked to get the recommendations changed, to improve the recommendations to what we currently have, to “everyone 6 months and older should receive an annual flu shot.” So, this week, we’ve been going back into the archive, trying to gather some of that old data to show how the rates reflect the mortality and hospitalizations, too. As far as rates go, they align right now. And it’s exciting to see, since mid-December, the rates start to trickle upwards for all ages. Not as fast as we want, but at least upwards, and starting to exceed where we were last year.
Q/Follow-up: Do you anticipate that that’s really because there’s been some really good media coverage about the potential of a severe flu season?
Michele Slafkosky (FFF): I’d like to think it also has to do with FFF, getting our stories out there clearly and the comic book and the messaging … having diverse messaging coming from so many different voices. But absolutely, with the severity of the flu, and as cases were rising, we’d like to think it’s all of us working together with that message that the vaccine works, and you’re better to be protected by getting vaccinated versus not, that that’s [all] driving people to go get those shots.
 We started a “headline news” newsletter this past week [that will be sent every Tuesday], where we compare year-to-year data about where we are, and we’re going to include that in this Tuesday’s update. If anybody is interested in receiving that, please reach out so we can add you to that newsletter distribution. It’s good data, and week over week for the last few weeks, we’ve been doubling or almost doubling the number of hospitalizations, deaths, and illnesses. And it’s really sad to see those numbers increase so rapidly, and we’re very concerned with what we’re going to see with the surveillance this next week.

BACK TO TOP

Announcements
  • Save the date for the 2026 National Adult and Influenza Immunization Summit in-person meeting: May 19 – 21, 2026 at the Crowne Plaza Atlanta Perimeter at Ravinia in Atlanta, GA.
    • Registration opened on January 12, 2026 at https://www.izsummitpartners.org/2026-naiis/.
    • Nominations for the Immunization Champion Awards (the Immunization Neighborhood Champion and the Laura Scott Flu Award) are welcome, and there will be a scientific poster session that will be open to submissions.

BACK TO TOP

Search: